查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1666331

Adenosine(ATP) 測定全球市場報告 2025

Adenosine Triphosphate (ATP) Assays Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年三磷酸Adenosine（ATP）檢測的市場規模將快速成長。 2029 年將成長至 34.6 億美元，年複合成長率（CAGR）為 12.0%。預測期內的成長可歸因於生物製藥行業的持續成長、對個人化醫療方法的日益關注、對食品和飲料安全的日益重視、檢測平台的技術創新以及工業過程中的應用不斷擴大。預測期內的主要趨勢包括 ATP 檢測技術的進步、對高通量篩檢的需求不斷成長、與臨床診斷的整合、對食品和飲料安全測試的日益重視以及在體育和表現監測中的應用。

癌症、慢性病和感染疾病率的上升預計將推動Adenosine腺苷 (ATP) 檢測市場的未來成長。癌症的特徵是細胞生長不受控制，可以侵入和破壞附近組織並擴散到身體的其他部位。慢性病是一種穩定的疾病，通常發展緩慢並持續很長一段時間。感染疾病是由細菌、病毒、真菌和寄生蟲等病原微生物引起的，可在人與人之間傳播。 ATP 檢測可以評估細胞活力、檢測微生物污染、評估治療效果以及監測代謝和粒線體功能障礙，是這些疾病的重要診斷工具。例如，2024 年 2 月，總部位於瑞士的聯合國機構世界衛生組織 (WHO) 預測，到 2050 年，癌症新病例將超過 3,500 萬例，比 2022 年預計的 2,000 萬例增加 77%。此外，2021 年，專注於糖尿病社區的比利時組織國際糖尿病聯合會報告稱，約有 5.37 億成年人患有糖尿病，並預測到 2045 年這一數字將上升到 7.83 億。因此，癌症、慢性病和感染疾病的增加正在推動 ATP 測量設備市場的發展。

個人化治療方法的需求不斷成長，預計將刺激三磷酸Adenosine(ATP) 檢測市場的擴張。個人化醫療涉及利用個人獨特的基因和蛋白質組成的知識來有效地預防、檢測和治療疾病。在感染疾病治療中，ATP測定對於評估抗生素針對特定病原體的療效、幫助選擇個人化的治療策略具有重要作用。例如，根據個人化醫療聯盟報告，美國食品藥物管理局（FDA）在2022年核准了12種個人化藥物，約佔所有新核准治療分子實體的34%。個人化醫療需求的激增必將在推動Adenosine磷酸腺苷 (ATP) 檢測市場的成長方面發揮關鍵作用。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球三Adenosine(ATP) 檢測市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球Adenosine腺苷 (ATP) 檢測市場：成長率分析
  • 全球Adenosine腺苷 (ATP) 檢測市場表現：規模與成長，2019 年至 2024 年
  • 全球三Adenosine腺苷 (ATP) 檢測市場預測：規模和成長，2024-2029 年，2034 年
  • 全球三Adenosine(ATP) 測定總目標市場 (TAM)

第6章 市場細分

  • 全球三Adenosine腺苷 (ATP) 檢測市場類型、績效及預測，2019-2024、2024-2029、2034
  • 發光 ATP（三Adenosine腺苷）測定
  • 酵素 ATP（Adenosine腺苷）測定
  • 生物發光共振能量轉移 (BRET) ATP（三Adenosine腺苷）測定
  • 基於細胞的 ATP（Adenosine腺苷）測定
  • 其他
  • 全球三Adenosine腺苷 (ATP) 檢測市場成分、效能及預測，2019-2024、2024-2029、2034
  • 耗材及配件
  • 裝置
  • 全球三Adenosine腺苷 (ATP) 檢測市場的應用、性能和預測，2019-2024、2024-2029、2034
  • 藥物研發
  • 臨床診斷
  • 環境測試
  • 食品安全和品質檢測
  • 其他
  • 全球三Adenosine腺苷 (ATP) 檢測市場（按最終用戶、績效和預測）2019-2024、2024-2029、2034
  • 製藥和生物技術公司
  • 食品和飲料
  • 醫院和診斷實驗室
  • 學術研究所
  • 全球Adenosine(ATP) 檢測市場：發光 ATP 檢測細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 基於螢光素酶的檢測
  • 化學冷光分析
  • 全球Adenosine腺苷 (ATP) 測定市場：酶促 ATP 測定細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 基於激酶的檢測
  • ATPase活性測定
  • 全球Adenosine腺苷 (ATP) 檢測市場：生物發光共振能量轉移 (BRET) ATP 檢測細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • BRET 用於蛋白質-蛋白質交互作用
  • BRET 用於藥物研發
  • 全球Adenosine腺苷 (ATP) 檢測市場：基於細胞的 ATP 檢測細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 活細胞 ATP 測量
  • 細胞活力測定
  • 全球三Adenosine(ATP) 測定市場：其他細分市場：按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 螢光ATP 測定
  • 光強度ATP 測定

第7章 區域和國家分析

  • 全球三Adenosine腺苷 (ATP) 檢測市場各地區、績效及預測，2019-2024、2024-2029、2034
  • 全球三Adenosine腺苷 (ATP) 檢測市場（按國家/地區分類）、績效及預測，2019-2024、2024-2029、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

  • 三Adenosine(ATP) 檢測市場：競爭格局
  • Adenosine腺苷 (ATP) 檢測市場：公司簡介
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • Promega Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Agilent Technologies Inc.
  • Abcam plc
  • Danaher Corporation
  • 3M Co.
  • Geno Technology Inc.
  • NEOGEN Corporation
  • Biomerieux SA
  • AAT Bioquest Inc.
  • MBL International Corporation
  • Charm Sciences Inc.
  • Cell Signaling Technology Inc.
  • Cayman Chemical Company
  • Vazyme Biotech Co. Ltd.
  • SignalChem Lifesciences Corporation
  • Kaneka Corporation

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • Adenosine腺苷 (ATP) 檢測市場 2029：提供新機會的國家
  • Adenosine(ATP) 檢測市場 2029：細分市場提供新機會
  • Adenosine腺苷 (ATP) 檢測市場 2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 36 章 附錄

簡介目錄
Product Code: r23864

ATP assays, or adenosine triphosphate assays, serve as analytical procedures to determine ATP concentrations in biological materials. ATP, an energy-carrying molecule present in cells of all living organisms, extracts chemical energy from the breakdown of food molecules and utilizes it to power various cellular functions. This assay plays a crucial role in monitoring cellular energy state and function, serving as a vital tool in research, diagnostics, and drug discovery.

The primary types of ATP assays include luminometric ATP assays, enzymatic ATP assays, bioluminescence resonance energy transfer (BRET) ATP assays, cell-based ATP assays, among others. Luminometric ATP assays, specifically, leverage bioluminescence principles to measure ATP levels in samples. They are widely used in research, drug discovery, and biomedical applications for assessing cellular energy status, measuring enzymatic activity, evaluating cell viability, and screening ATP-modulating compounds. These assays consist of essential components such as consumables, accessories, and instruments utilized across diverse fields including drug discovery and development, clinical diagnostics, environmental testing, and food safety and quality assessment. Their applications extend to various end-users such as pharmaceutical and biotechnology companies, the food and beverage industry, hospitals, diagnostics laboratories, as well as academic and research institutions.

The adenosine triphosphate (ATP) assays market research report is one of a series of new reports from The Business Research Company that provides adenosine triphosphate (ATP) assays market statistics, including adenosine triphosphate (ATP) assays industry global market size, regional shares, competitors with an adenosine triphosphate (ATP) assays market share, detailed adenosine triphosphate (ATP) assays market segments, market trends and opportunities, and any further data you may need to thrive in the adenosine triphosphate (ATP) assays industry. This adenosine triphosphate (ATP) assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adenosine triphosphate (ATP) assays market size has grown rapidly in recent years. It will grow from$1.99 billion in 2024 to $2.2 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to biomedical research advancements, drug discovery and development, rise in adoption in clinical diagnostics, environmental monitoring requirements, increased focus on cell-based assays

The adenosine triphosphate (ATP) assays market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to continued growth in biopharmaceutical industry, expansion of personalized medicine approaches, increased emphasis on food and beverage safety, technological innovations in assay platforms, growing application in industrial processes. Major trends in the forecast period include advancements in ATP detection technologies, rising demand for high-throughput screening, integration in clinical diagnostics, emphasis on food and beverage safety testing, application in sports and performance monitoring.

The rising incidence of cancer, chronic diseases, and infectious diseases is projected to drive the growth of the adenosine triphosphate (ATP) assay market in the future. Cancer is marked by uncontrolled cell growth that can invade and damage nearby tissues and may spread to other parts of the body. Chronic diseases are stable conditions that generally develop slowly and persist over a long period. Infectious diseases are caused by pathogenic microorganisms that can be transmitted from one person to another, including bacteria, viruses, fungi, or parasites. ATP assays serve as an important diagnostic tool for these diseases by evaluating cellular viability, detecting microbial contamination, assessing treatment effectiveness, and monitoring metabolic and mitochondrial dysfunction. For example, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that over 35 million new cancer cases will occur by 2050, representing a 77% increase from an estimated 20 million cases in 2022. Additionally, in 2021, the International Diabetes Federation, a Belgium-based organization focused on the diabetic community, reported that approximately 537 million adults have diabetes, with that number expected to rise to 783 million by 2045. Therefore, the growing prevalence of cancer, chronic, and infectious diseases is driving the ATP assay market.

The growing demand for personalized treatment approaches is expected to fuel the expansion of the adenosine triphosphate (ATP) assays market. Personalized treatments involve utilizing knowledge about an individual's unique genetic or protein makeup to prevent, detect, or treat diseases effectively. In the context of infectious disease management, ATP assays play a crucial role by assessing the efficacy of antimicrobial agents against specific pathogens, aiding in the selection of personalized treatment strategies. For instance, the US Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, constituting around 34% of all newly approved therapeutic molecular entities, as reported by the Personalized Medicine Coalition. This surge in demand for personalized medicine underscores its pivotal role in driving the growth of the adenosine triphosphate (ATP) assays market.

The rising prevalence of chronic diseases is projected to drive the growth of the adenosine triphosphate (ATP) assays market in the coming years. Chronic diseases are illnesses that persist for three months or longer and can worsen over time. Several factors contribute to the increasing prevalence of these conditions, including an aging population, unhealthy lifestyle choices, and rapid urbanization, which lead to a rise in diseases such as diabetes, cardiovascular disease, and respiratory illnesses. ATP, the main energy carrier in cells, is measured through ATP assays to investigate disruptions in cellular energy metabolism, which are often linked to chronic diseases like diabetes, cancer, and neurodegenerative disorders. This understanding helps researchers better comprehend disease progression and develop new therapeutic strategies. For example, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that over 35 million new cancer cases will be diagnosed by 2050, representing a 77% increase from the estimated 20 million cases in 2022. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the ATP assays market.

The evolution of novel assays stands out as a prominent trend gaining momentum within the adenosine triphosphate (ATP) assay market. Key companies operating in this domain are introducing groundbreaking products, such as the SensiLux kit by BC Aplicaciones, a biotechnology firm based in Spain. The SensiLux kit is a unique testing solution designed for detecting microbial ATP in samples, utilizing bioluminescence for detection following sample pre-incubation. Its applications extend to areas such as food safety and contamination testing. Additionally, this offering includes ATP kits featuring advanced multi-injector automatic luminometers, proprietary control software, and future-oriented robot-based sample automation, providing customers with tailored solutions. BC Aplicaciones' programming and computer systems department have developed unique software to manage robot and luminometer operations.

Leading companies in the adenosine triphosphate (ATP) assays market are concentrating on creating advanced kinase testing platforms to offer highly sensitive assays. A kinase testing platform is a specialized system designed to assess kinase activity in biological samples, supporting drug discovery and development by providing insights into kinase function and inhibition. For example, in April 2024, Reaction Biology, a biotechnology firm based in the U.S., launched the HotSpot(TM) ATP-Max KinomeScreen, an advanced assay for high-throughput kinase screening that features enhanced sensitivity, allowing testing at ATP levels as low as 1 mM. This innovative platform utilizes a gold standard filter binding radiometric assay to assess kinase activity across the broadest range of kinase targets in the industry. By providing physiologically relevant data, the HotSpot ATP-Max KinomeScreen enables researchers to identify more potent and specific kinase inhibitors, thereby advancing drug discovery efforts and aiding the development of targeted therapies for various diseases, particularly cancer.

Major companies operating in the adenosine triphosphate (ATP) assays market include Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, 3M Co., Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adenosine triphosphate (atp) assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adenosine triphosphate (ATP) assays market consists of revenues earned by entities by providing testing services related to colorimetric and fluorescent assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The adenosine triphosphate (ATP) assays market also includes sales of luminometer, and chemiluminescent which are used in adenosine triphosphate (ATP) assay services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adenosine Triphosphate (ATP) Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adenosine triphosphate (atp) assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adenosine triphosphate (atp) assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adenosine triphosphate (atp) assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays; Enzymatic ATP (Adenosine Triphosphate) Assays; Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays; Cell-Based ATP (Adenosine Triphosphate) Assays; Other Types
  • 2) By Component: Consumables And Accessories; Instruments
  • 3) By Application: Drug Discovery And Development; Clinical Diagnostics; Environmental Testing; Food Safety And Quality Testing; Other Applications
  • 4) By End User: Pharmaceutical And Biotechnology Companies; Food and Beverage Industry; Hospitals And Diagnostics Laboratories; Academic And Research Institutions
  • Subsegments:
  • 1) By Luminometric ATP Assays: Luciferase-Based Assays; Chemiluminescent Assays
  • 2) By Enzymatic ATP Assays: Kinase-Based Assays; ATPase Activity Assays
  • 3) By Bioluminescence Resonance Energy Transfer (BRET) ATP Assays: BRET For Protein-Protein Interactions; BRET For Drug Discovery
  • 4) By Cell-Based ATP Assays: Live-Cell ATP Measurement; Cell Viability Assays
  • 5) By Other Types: Fluorescent ATP Assays; Spectrophotometric ATP Assays
  • Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Lonza Group; Promega Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Adenosine Triphosphate (ATP) Assays Market Characteristics

3. Adenosine Triphosphate (ATP) Assays Market Trends And Strategies

4. Adenosine Triphosphate (ATP) Assays Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Adenosine Triphosphate (ATP) Assays Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Adenosine Triphosphate (ATP) Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Adenosine Triphosphate (ATP) Assays Market Growth Rate Analysis
  • 5.4. Global Adenosine Triphosphate (ATP) Assays Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Adenosine Triphosphate (ATP) Assays Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Adenosine Triphosphate (ATP) Assays Total Addressable Market (TAM)

6. Adenosine Triphosphate (ATP) Assays Market Segmentation

  • 6.1. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luminometric ATP (Adenosine Triphosphate) Assays
  • Enzymatic ATP (Adenosine Triphosphate) Assays
  • Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays
  • Cell-Based ATP (Adenosine Triphosphate) Assays
  • Other Types
  • 6.2. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables And Accessories
  • Instruments
  • 6.3. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Clinical Diagnostics
  • Environmental Testing
  • Food Safety And Quality Testing
  • Other Applications
  • 6.4. Global Adenosine Triphosphate (ATP) Assays Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Food and Beverage Industry
  • Hospitals And Diagnostics Laboratories
  • Academic And Research Institutions
  • 6.5. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Luminometric ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luciferase-Based Assays
  • Chemiluminescent Assays
  • 6.6. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Enzymatic ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kinase-Based Assays
  • ATPase Activity Assays
  • 6.7. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Bioluminescence Resonance Energy Transfer (BRET) ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • BRET For Protein-Protein Interactions
  • BRET For Drug Discovery
  • 6.8. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Cell-Based ATP Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Live-Cell ATP Measurement
  • Cell Viability Assays
  • 6.9. Global Adenosine Triphosphate (ATP) Assays Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fluorescent ATP Assays
  • Spectrophotometric ATP Assays

7. Adenosine Triphosphate (ATP) Assays Market Regional And Country Analysis

  • 7.1. Global Adenosine Triphosphate (ATP) Assays Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Adenosine Triphosphate (ATP) Assays Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market

  • 8.1. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adenosine Triphosphate (ATP) Assays Market

  • 9.1. China Adenosine Triphosphate (ATP) Assays Market Overview
  • 9.2. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adenosine Triphosphate (ATP) Assays Market

  • 10.1. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adenosine Triphosphate (ATP) Assays Market

  • 11.1. Japan Adenosine Triphosphate (ATP) Assays Market Overview
  • 11.2. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adenosine Triphosphate (ATP) Assays Market

  • 12.1. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adenosine Triphosphate (ATP) Assays Market

  • 13.1. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adenosine Triphosphate (ATP) Assays Market

  • 14.1. South Korea Adenosine Triphosphate (ATP) Assays Market Overview
  • 14.2. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adenosine Triphosphate (ATP) Assays Market

  • 15.1. Western Europe Adenosine Triphosphate (ATP) Assays Market Overview
  • 15.2. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adenosine Triphosphate (ATP) Assays Market

  • 16.1. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adenosine Triphosphate (ATP) Assays Market

  • 17.1. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adenosine Triphosphate (ATP) Assays Market

  • 18.1. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adenosine Triphosphate (ATP) Assays Market

  • 19.1. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adenosine Triphosphate (ATP) Assays Market

  • 20.1. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adenosine Triphosphate (ATP) Assays Market

  • 21.1. Eastern Europe Adenosine Triphosphate (ATP) Assays Market Overview
  • 21.2. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adenosine Triphosphate (ATP) Assays Market

  • 22.1. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adenosine Triphosphate (ATP) Assays Market

  • 23.1. North America Adenosine Triphosphate (ATP) Assays Market Overview
  • 23.2. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adenosine Triphosphate (ATP) Assays Market

  • 24.1. USA Adenosine Triphosphate (ATP) Assays Market Overview
  • 24.2. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adenosine Triphosphate (ATP) Assays Market

  • 25.1. Canada Adenosine Triphosphate (ATP) Assays Market Overview
  • 25.2. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adenosine Triphosphate (ATP) Assays Market

  • 26.1. South America Adenosine Triphosphate (ATP) Assays Market Overview
  • 26.2. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adenosine Triphosphate (ATP) Assays Market

  • 27.1. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adenosine Triphosphate (ATP) Assays Market

  • 28.1. Middle East Adenosine Triphosphate (ATP) Assays Market Overview
  • 28.2. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adenosine Triphosphate (ATP) Assays Market

  • 29.1. Africa Adenosine Triphosphate (ATP) Assays Market Overview
  • 29.2. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Adenosine Triphosphate (ATP) Assays Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape And Company Profiles

  • 30.1. Adenosine Triphosphate (ATP) Assays Market Competitive Landscape
  • 30.2. Adenosine Triphosphate (ATP) Assays Market Company Profiles
    • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Promega Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Adenosine Triphosphate (ATP) Assays Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Abcam plc
  • 31.3. Danaher Corporation
  • 31.4. 3M Co.
  • 31.5. Geno Technology Inc.
  • 31.6. NEOGEN Corporation
  • 31.7. Biomerieux SA
  • 31.8. AAT Bioquest Inc.
  • 31.9. MBL International Corporation
  • 31.10. Charm Sciences Inc.
  • 31.11. Cell Signaling Technology Inc.
  • 31.12. Cayman Chemical Company
  • 31.13. Vazyme Biotech Co. Ltd.
  • 31.14. SignalChem Lifesciences Corporation
  • 31.15. Kaneka Corporation

32. Global Adenosine Triphosphate (ATP) Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adenosine Triphosphate (ATP) Assays Market

34. Recent Developments In The Adenosine Triphosphate (ATP) Assays Market

35. Adenosine Triphosphate (ATP) Assays Market High Potential Countries, Segments and Strategies

  • 35.1 Adenosine Triphosphate (ATP) Assays Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Adenosine Triphosphate (ATP) Assays Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Adenosine Triphosphate (ATP) Assays Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer